Nebraska: Dupixent (dupilumab) litigation | DrugsMonitor.com

Dupixent (dupilumab) litigation in Nebraska (NE): MDL-linked practice notes, filing-deadline context, confidential review—not legal advice.

dupilumab, atopic dermatitis, asthma, ocular surface disease, keratitis, vision injury, Nebraska